Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Eyes and Ocular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00237627
What this trial is testing

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05180461
What this trial is testing

Emodepside Phase II Trial for Treatment of Onchocerciasis

Who this might be right for
Onchocerciasis
Drugs for Neglected Diseases 578
Not applicableAvailableNCT04776694
What this trial is testing

Compassionate Use or Expanded Access of Dupilumab

Who this might be right for
Type 2 Inflammatory Disorders
Regeneron Pharmaceuticals
Not applicableStudy completedNCT00806182
What this trial is testing

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

Who this might be right for
Opsoclonus-myoclonus Syndrome
National Pediatric Neuroinflammation Organization, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT00391924
What this trial is testing

Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome

Who this might be right for
Lupus Erythematosus, SystemicSjogren's Syndrome
UMC Utrecht 120
Not applicableLooking for participantsNCT05004493
What this trial is testing

Biorepository and Registry for Plasma Exchange Patients

Who this might be right for
Antibody-mediated RejectionNMO Spectrum DisorderTTP+1 more
Charles M Knudson 200
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Not applicableStudy completedNCT00001192
What this trial is testing

Neuropsychological Evaluation of Psychiatric and Neurological Patients

Who this might be right for
Anxiety DisorderHead InjuryMood Disorder+2 more
National Institute of Mental Health (NIMH) 4,300
Not applicableEnrolling By InvitationNCT06583395
What this trial is testing

Quest to Analyze One Thousand Humans Meditating

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Angina, StableAnxiety+52 more
Tobias Moeller-Bertram 3,000
Not applicableLooking for participantsNCT06500728
What this trial is testing

Visual Involvement in Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisVisual ImpairmentCentral Retinal Artery Occlusion+6 more
ASST Fatebenefratelli Sacco 762
Not applicableNot Yet RecruitingNCT07650110
What this trial is testing

Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2

Who this might be right for
CADASILCavernous AngiomaCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy+1 more
Assistance Publique - Hôpitaux de Paris 600
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Ended earlyNCT02109224
What this trial is testing

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT01326702
What this trial is testing

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more
National Cancer Institute (NCI) 43
Not applicableActive Not RecruitingNCT01199562
What this trial is testing

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more
City of Hope Medical Center 153
Testing effectiveness (Phase 2)Looking for participantsNCT07136181
What this trial is testing

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more
Novelwise Pharmaceutical Corporation 36
Early research (Phase 1)Study completedNCT00994500
What this trial is testing

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germ Cell Tumor+32 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo